BRG Borregaard

Borregaard ASA: EBITDA1 of NOK 327 million in the 4th quarter

Borregaard ASA: EBITDA1 of NOK 327 million in the 4th quarter

Borregaard’s operating revenues were NOK 1,605 million (NOK 1,770 million)2 in the 4th quarter of 2023. EBITDA1 was NOK 327 million (NOK 364 million). The result in BioSolutions improved while BioMaterials’ and Fine Chemicals’ results were lower compared with the 4th quarter of 2022. Operational issues at the Sarpsborg site and lower demand for and sales of biovanillin had a negative impact in the 4th quarter of approximately NOK 80 million.

In BioSolutions, reduced energy costs were partly offset by reduced sales volume and cost inflation in general. The reduced result in BioMaterials was mainly due to the operational issues at the Sarpsborg site. In Fine Chemicals, lower production volume and lower sales prices in fine chemical intermediates had a negative impact on EBITDA1 compared with the 4th quarter of 2022. The net currency effects were positive for the Group.

Profit before tax was NOK 135 million (NOK 210 million). Earnings per share were NOK 1.20 (NOK 1.85).

Full year 2023

Operating revenues increased to NOK 7,132 million (NOK 6,881 million). EBITDA1 reached an all-time high of NOK 1,781 million (NOK 1,643 million). Profit before tax was NOK 1,124 million (NOK 1,118 million). Earnings per share were NOK 8.73 (NOK 8.95).

- We are pleased to deliver an all-time high result in a year with challenging macroeconomic conditions, says President and CEO Per A. Sørlie.

Contacts:

Director Investor Relations, Knut-Harald Bakke, +47 905 79 164

Director Communications, Tone Horvei Bredal, +47 924 67 711

1. Operating profit before depreciation, amortisation and other income and expenses

2. Figures in parentheses are for the corresponding period in the preceding year

This information is considered to be inside information pursuant to the EU Market Abuse Regulation and is subject to the disclosure requirements pursuant to Section 5 – 12 of the Norwegian Securities Trading Act.

This stock exchange announcement was published by Lotte Kvinlaug, Investor Relations Officer at Borregaard ASA, on 31 January 2024 at 07:00 CET.

 

Attachments



EN
31/01/2024

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Borregaard

 PRESS RELEASE

Borregaard ASA: Reporting of transactions in Borregaard ASA's shares m...

Borregaard ASA: Reporting of transactions in Borregaard ASA's shares made by person discharging managerial responsibilities Borregaard's Board of Directors has issued 30,000 share options in relation to the CEO appointment. Reference is made to stock exchange release on 23 May 2025. The options will expire after five years (1 August 2030) and may be exercised in the last two years. The strike price of the options is NOK 219.31, based on the volume-weighted average share price (VWAP) over the last three trading days in July 2025 (29, 30 and 31 July), plus a 10% premium. The strike price wil...

 PRESS RELEASE

Borregaard ASA: New CEO reinforces Borregaard’s commitment to speciali...

Borregaard ASA: New CEO reinforces Borregaard’s commitment to specialisation and value growth Tom Erik Foss-Jacobsen assumed his position as Borregaard’s new CEO on 1 August (see notice to Oslo Stock Exchange 23 May 2025). “Borregaard is well positioned with six production units, three R&D centres, and thirteen sales offices in key markets across Europe, the Americas, and Asia. We will continue to build on this solid foundation and our highly skilled organisation to advance our strategy of specialisation and value growth. Borregaard will continue to build on a strong legacy of specialisati...

ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
ABGSC Pulp & Paper Research ... (+3)
  • ABGSC Pulp & Paper Research
  • Henrik Bartnes
  • Martin Melbye
 PRESS RELEASE

Borregaard ASA: EBITDA1 of NOK 522 million in the 2nd quarter

Borregaard ASA: EBITDA1 of NOK 522 million in the 2nd quarter Borregaard’s operating revenues increased to NOK 2,045 million (NOK 1,949 million)2 in the 2nd quarter of 2025. EBITDA1 reached NOK 522 million (NOK 510 million). The result in BioSolutions and BioMaterials increased while Fine Chemicals had a lower result. Continued growth in sales to agriculture was the main reason for the improved result in BioSolutions. In BioMaterials, the result increased due to higher sales prices, improved product mix and increased sales volume, partly offset by higher wood costs. Lower sales prices for b...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch